IonQ Demonstrates Quantum-Accelerated Workflow for Drug Discovery with AstraZeneca, AWS, and NVIDIA
Mohamed Abdel-Kareem2026-03-17T13:19:12-07:00IonQ has announced a multi-party collaboration with AstraZeneca, AWS, and NVIDIA to demonstrate a hybrid quantum-classical workflow aimed at accelerating early-stage pharmaceutical development. The workflow, showcased at ISC High Performance 2025, achieved a 20x speedup in time-to-solution compared to previous approaches while modeling catalytic steps in Suzuki-Miyaura cross-coupling—a reaction class essential to small-molecule drug synthesis. The end-to-end solution integrates IonQ’s Forte quantum processing unit (QPU), NVIDIA’s CUDA-Q platform, and AWS cloud infrastructure, including Braket and ParallelCluster. This combination allowed accurate simulation of complex chemical pathways, significantly reducing the expected computational runtime from months to days. The result highlights how quantum acceleration [...]